目錄:MedChemExpress LLC>>信號(hào)通路>> Adagrasib | MedChemExpress (MCE)
參考價(jià) | ¥ 1270 |
參考價(jià) | ¥ 1270 |
更新時(shí)間:2023-11-30 11:28:10瀏覽次數(shù):180評(píng)價(jià)
聯(lián)系我們時(shí)請(qǐng)說(shuō)明是化工儀器網(wǎng)上看到的信息,謝謝!
CAS | 2326521-71-3 | 純度 | 99.93% |
---|---|---|---|
分子量 | 604.12 | 分子式 | C??H??ClFN?O? |
供貨周期 | 現(xiàn)貨 | 規(guī)格 | 10 mM * 1 mL |
貨號(hào) | HY-130149 | 應(yīng)用領(lǐng)域 | 醫(yī)療衛(wèi)生,化工,生物產(chǎn)業(yè),制藥 |
MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報(bào),我們不為任何個(gè)人用途提供產(chǎn)品和服務(wù)。
CAS No. : 2326521-71-3
MCE 國(guó)際站:Adagrasib
產(chǎn)品活性:Adagrasib (MRTX849) 是一種有效,口服可用,突變選擇性的 KRAS G12C 共價(jià)抑制劑,具有潛在抗腫瘤活性的。Adagrasib 在半胱氨酸 12 殘基處與 KRAS G12C 共價(jià)結(jié)合,將蛋白鎖定在非活性的 GDP 結(jié)合構(gòu)象中,并抑制 KRAS 依賴性信號(hào)轉(zhuǎn)導(dǎo)。
研究領(lǐng)域:GPCR/G Protein
作用靶點(diǎn):Ras
In Vitro: Adagrasib (MRTX849) (0.1-10000 nM; 3-day/2D conditions; 12-day/3D conditions) potently inhibits cell growth in the vast majority of KRAS G12C-mutant cell lines with IC50s ranging between 10 and 973 nM in the 2D format and between 0.2 and 1042 nM in the 3D format.
Adagrasib (0.24-1000 nM; 24 hours) inhibits KRAS-dependent signaling targets including ERK1/2 phosphorylation (Thr202/Tyr204 ERK1; pERK), S6 phosphorylation (RSK-dependent Ser235/236; pS6) and expression of the ERK-regulated DUSP6.
In Vivo: Adagrasib (1-100 mg/kg; i.g.; daily until day 16) demonstrates dose-dependent anti-tumor efficacy over a well-tolerated dose range, and the maximally efficacious dose of MRTX849 is between 30-100 mg/kg/day.
相關(guān)產(chǎn)品:Covalent Screening Library Plus | Drug Repurposing Compound Library Plus | Clinical Compound Library Plus | Bioactive Compound Library Plus | GPCR/G Protein Compound Library | Kinase Inhibitor Library | Anti-Cancer Compound Library | Clinical Compound Library | Drug Repurposing Compound Library | Covalent Screening Library | Ferroptosis Compound Library | Orally Active Compound Library | Chemical Probe Library | Glutamine Metabolism Compound Library | Anti-Lung Cancer Compound Library | Anti-Pancreatic Cancer Compound Library | Anti-Blood Cancer Compound Library | Angiogenesis-Related Compound Library | Anti-Liver Cancer Compound Library | Anti-Colorectal Cancer Compound Library | Membrane Protein-targeted Compound Library | Membrane Receptor-targeted Compound Library | Highly Selective Inhibitors Library | LC-2 | KRAS G12C inhibitor 54 | MRTX1133 | AZA1 | RBC10 | CFL-137 | Deltarasin hydrochloride | BDP9066 | CCG-100602 | KRAS inhibitor-4 | KRas G12R inhibitor 1 | MRTX0902 | KRAS G12C inhibitor 25 | PAT-IN-2 | Antitumor agent-60 | KRAS G12C inhibitor 30 | KRas G12C inhibitor 1 | Spiclomazine hydrochloride | GGTI-286 hydrochloride | 6H05 | AZD4625 | SOS1-IN-6 | Antineoplaston A10 | Opnurasib | K-Ras-IN-1 | BI-0474 | Diazepinomicin | K20 | BQU57
熱門產(chǎn)品線:重組蛋白 | 化合物庫(kù) | 天然產(chǎn)物 | 熒光染料 | PROTAC | 同位素標(biāo)記物 | 寡核苷酸 | 抗體 | 點(diǎn)擊化學(xué)
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
(空格分隔,最多3個(gè),單個(gè)標(biāo)簽最多10個(gè)字符)